drugset
drugset / Trial / NCT06066099

Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969

NCT06066099 ↗

Phase 1 Completed 92 enrolled Acesion Pharma
RandomizedSequentialDouble-blindBasic science

Summary

The primary objective of the study is to evaluate the safety and tolerability of single doses (Part A) and multiple doses (Part B) of AP31969 in healthy participants.

Timeline

Start
2023-10-04
Primary completion
2025-03-14
Completion
2025-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject AP31969 Unknown — Oral

Indications

No indication recorded.